Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives

Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives

US Patent 7125881 · Granted Oct 24, 2006

Estimated economic value: $7,845,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds2025
Orexin 1 receptor antagonists2025
Oxexin 1 receptor antagonists2025
Sulfonamide carboxamide compounds2025
Sulfonamide carboxamide compounds2024
Hydrocarbon functionalized carbon-based nanomaterial and method2024
Sulfonamide carboxamide compounds2024
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors2024
Water soluble pyranine polymers and method of making2024
Alkali-swellable multi-functional rheology modifiers2023
Sulfonamide carboxamide compounds2023
Processes2023